The Use of Biomarkers in Pharmacovigilance: A Systematic Review of the Literature.
Maribel SalasMaxine Gossell-WilliamsPriyanka YalamanchiliSameer DhingraMarina A MalikovaOmar AimerToluwalope JunaidPublished in: Biomarker insights (2023)
Various categories of biomarkers including safety, predictive, pharmacodynamic/response, and diagnostic biomarkers are being investigated for potential use in pharmacovigilance. The most frequent potential uses of biomarkers in pharmacovigilance in the literature were the prediction of the severity of an ADR, mortality, response, safety, and toxicity. The safety biomarkers identified were used to evaluate patient safety during dose escalation, identify patients who may benefit from further biomarker testing during treatment, and monitor ADRs.